Cargando…
Higher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia
BACKGROUND: Although the biological insight of acute myeloid leukemia (AML) has increased in the past few years, the discovery of novel discriminative biomarkers remains of utmost value for improving outcome predictions. Systematical studies concerning the clinical implications and genetic correlati...
Autores principales: | Gao, Li, Sun, Junzhong, Liu, Fang, Zhang, Hui, Ma, Yigai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755436/ https://www.ncbi.nlm.nih.gov/pubmed/26929642 http://dx.doi.org/10.2147/OTT.S95279 |
Ejemplares similares
-
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
por: Sun, Q-Y, et al.
Publicado: (2017) -
TIFAB accelerates MLL-AF9−Induced acute myeloid leukemia through upregulation of HOXA9
por: Zhao, Jinming, et al.
Publicado: (2021) -
Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens
por: Wright, Shaela, et al.
Publicado: (2023) -
Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome
por: Kong, Jun, et al.
Publicado: (2022) -
MOZ is critical for the development of MOZ/MLL fusion–induced leukemia through regulation of Hoxa9/Meis1 expression
por: Katsumoto, Takuo, et al.
Publicado: (2022)